Perindopril Erbumine Tablet
Product Images NDC 65862-287

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Perindopril Erbumine (NDC 65862-287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Perindopril Fig1)

A line chart titled 'Time to First Occurrence of Primary Endpoint' showing the proportion of patients with cardiovascular mortality, myocardial infarction, or cardiac arrest over time (years). Two groups are compared: Placebo and Perindopril. The graph includes a logrank p-value of 0.0003 and shows the number of patients at risk for each group at several time points up to 5 years.*

FDA Label Image

Figure 2. Beneficial Effect Of Perindopril Treatment On Primary Endpoint In Predefined Subgroups (Perindopril Fig2)

A forest plot figure titled 'Beneficial Effect of Perindopril Treatment on Primary Endpoint in Predefined Subgroups' showing comparison of primary event percentages between Perindopril and placebo groups across various subgroups such as gender, age ranges, prior medical history, and medication use. The plot illustrates relative risk with confidence intervals, indicating treatment effects favoring Perindopril or placebo across these subgroups.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablet Bottle))

Label for Perindopril Erbumine Tablets USP 2 mg by Aurobindo Pharma Limited. The label indicates 100 tablets for prescription use only, with storage instructions and distribution information from Aurobindo Pharma USA, Inc. It includes dosing directions reference and a barcode.*

FDA Label Image

Package Label-principal Display Panel (4 mg (100 Tablet Bottle))

Label for Perindopril Erbumine Tablets USP 4 mg from Aurobindo Pharma Limited. The label states the dosage strength as 4 mg per tablet and indicates a package size of 100 tablets. It includes storage instructions, a barcode, distribution information for Aurobindo Pharma USA, Inc., and regulatory codes.*

FDA Label Image

Package Label-principal Display Panel (8 mg (100 Tablet Bottle))

Label for Perindopril Erbumine Tablets USP 8 mg by Aurobindo Pharma Limited. The label indicates the tablet strength as 8 mg, the quantity as 100 tablets, and includes storage instructions. The label notes the product is Rx only, manufactured in India, and includes distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Perindopril Str)

Chemical structure of Perindopril Erbumine, a molecule showing its atomic connectivity and arrangement as associated with this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.